Reduction in Pain : Shockwave therapy has been shown to alleviate pain associated with Peyronies Disease, specifically through the triggering of the bodys nociceptors
Therapeutic-Model Protocol Dose: 0.50 1.00 mg (= 2040 clicks) Duration: 6 8 weeks Frequency: Daily Cycle Interval: 2 3 weeks off between cycles Goal / Description: Higher dose to assess enhanced lipolysis and energy utilization
doi: 10.1164/rccm.202108-1903LE 202 VermeulenRCWKurkRMVisserFCSluiterWScholteHR
Its primary application is in studies of oxidative stress
Free radical injury may also contribute to hair loss, aging skin, poor collagen formation, aches and pains, inflammation, metabolic imbalance, chronic fatigue, and weight gain
Growth hormone, insulin-like growth factor-1 and the aging cardiovascular system